Evidence map›Paper›PMID 30242129›Full record

ArticleThe Journal of biological chemistry2018

Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels.

Yasuhiro Hayashi, Yoko Nemoto-Sasaki, Naoki Matsumoto, Kotaro Hama, Takashi Tanikawa, Saori Oka, Tadaaki Saeki, Tatsuya Kumasaka, Takanori Koizumi, Seisuke Arai and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Effect of Total SMS Activity on LDL Catabolism in Mice.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  9. Article
  10. Sphingomyelin Synthase Family and Phospholipase Cs.Advances in experimental medicine and biology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Yasuhiro HayashiFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Yoko Nemoto-SasakiFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Naoki MatsumotoFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Kotaro HamaFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Takashi TanikawaFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Saori OkaFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Tadaaki SaekiFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Tatsuya KumasakaFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Takanori KoizumiFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Seisuke AraiDepartment of Cell Science, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
Ikuo WadaDepartment of Cell Science, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
Kazuaki YokoyamaFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Takayuki SugiuraFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and.
Atsushi YamashitaFrom the Faculty of Pharma-Science, Teikyo University, Tokyo 173- 8605, Japan and ayamashi@pharm.teikyo-u.ac.jp.ORCID 0000-0002-2544-2134
Teikyo University · JPFukushima Medical University · JPTeikyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingolipids, including sphingomyelin (SM) and glucosylceramide (GlcCer), are generated by the addition of a polar head group to ceramide (Cer). Sphingomyelin synthase 1 (SMS1) and glucosylceramide synthase (GCS) are key enzymes that catalyze the conversion of Cer to SM and GlcCer, respectively. GlcCer synthesis has been postulated to occur mainly in

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsChlorocebus aethiopsCOS CellsGene Knockdown TechniquesGlucosylceramidesGlucosyltransferasesHEK293 CellsHumansMembrane ProteinsMultienzyme ComplexesNerve Tissue ProteinsSequence DeletionSphingomyelinsTransferases (Other Substituted Phosphate Groups)ceramide glucosyltransferaseGlucosylceramidesGlucosyltransferasesMembrane ProteinsMultienzyme ComplexesNerve Tissue ProteinsSGMS1 protein, humanSphingomyelinsTransferases (Other Substituted Phosphate Groups)ceramidedimerizationfusion proteinglucosylceramide synthase (GCS)Golgilipid metabolismprotein domainsphingolipidsphingomyelin synthase 1 (SMS1)sterile α-motif (SAM) domain

Identifiers

PMID30242129
PMCPMC6231140
OpenAlexW2892338167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.